← FDA DRUG APPROVALS

FDA NDA · NDA018107

KIT FOR THE PREPARATION OF TECHNETIUM TC 99M MEDRONATE

technetium tc 99m medronate

Sponsor: CARDINAL HEALTH 414

APPLICATION
NDA018107
TYPE
NDA
ORIGINAL APPROVAL
1981-02-17
LATEST ACTION
2025-05-22
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

TECHNETIUM TC-99M MEDRONATE KITPrescription
TECHNETIUM TC-99M MEDRONATE KIT N/A · INJECTABLE · INJECTION

Approval history

2025-05-22Labeling · Supplement 17 · standardLetterAP
2020-11-13Labeling · Supplement 15 · standardLetterAP
2015-09-10Manufacturing (CMC) · Supplement 14 · standardAP
2014-02-21Manufacturing (CMC) · Supplement 12 · standardAP
2008-11-26Manufacturing (CMC) · Supplement 11 · standardLetterAP
1999-11-23Manufacturing (CMC) · Supplement 9 · standardAP
1997-03-04Manufacturing (CMC) · Supplement 4 · standardAP
1994-03-21Manufacturing (CMC) · Supplement 8 · standardAP
1993-03-24Labeling · Supplement 3AP
1993-03-24Labeling · Supplement 6AP
1992-09-30Manufacturing (CMC) · Supplement 7 · standardAP
1985-09-30Manufacturing (CMC) · Supplement 5 · standardAP
1982-04-12Labeling · Supplement 2AP
1981-04-13Manufacturing (CMC) · Supplement 1 · standardAP
1981-02-17Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →